Copyright © 2022 StrategyHelix Inc. All Rights Reserved.
Global Electronic Skin Patches Market - Outlook and Forecast 2022-2027
The global electronic skin patches market is projected to reach USD 28.82 billion by 2027, growing at a CAGR of 20.17% from 2021 to 2027. This growth can be attributed to several significant factors, including the increasing need for continuous monitoring of physiological parameters, the widespread use of wearable devices and mobile platforms for healthcare monitoring, the development of innovative skin patches, the rising demand for remote patient monitoring, the emerging trend of digital tattoos, supportive initiatives and reimbursement policies, and the growing number of start-ups focused on electronic skin patches.
Electronic skin patches are devices that are attached to a user’s skin and incorporate sensors, actuators, processors, and communication technology to provide specific functions. These patches have applications in various sectors and product categories, with cardiovascular monitoring and diabetes management being significant areas of growth. In cardiovascular monitoring, electronic skin patches range from traditional ECG options to specific products like Holter monitors and mobile cardiac telemetry devices.
|No. of Pages||
USD 9.6 billion in 2020
Application, End-User, and Geography
|No. of Companies Mentioned||
To stay ahead in the electronic skin patches market, several start-ups and universities are developing advanced sensor patches. For example, XSENSIO SA has created wearable devices that track biochemical information on the wearer’s skin surface. Scientists at the Georgia Institute of Technology have developed wireless wearable devices for measuring heart rate, electrocardiogram, respiratory rate, and motion activity. Some researchers have even designed flexible patches that detect blood-alcohol levels from sweat.
The growing burden of acute and chronic conditions has increased the need for continuous monitoring of patients, both in hospitals and at home. Cardiovascular diseases and other ailments require constant monitoring of vital signs, making electronic skin patches crucial in providing real-time data for effective management. Remote patient monitoring, which collects and tracks patient data outside of medical facilities, is also driving the adoption of electronic skin patches. These patches facilitate the transfer of patient information directly to healthcare providers or electronic medical records, particularly in cases involving the elderly and during pandemics.
The use of connected wearable medical devices is also contributing to the growth of the electronic skin patches market. These devices offer advantages such as continuous monitoring, health problem prediction, real-time data collection, and patient empowerment. By integrating with electronic skin patches, these devices provide convenience and further enhance the monitoring capabilities of users’ health. Software applications on mobile devices or smartwatches are often associated with these patches to facilitate data transmission and health monitoring.
The market is segmented based on various factors, including application, end-user, and geography.
Segmentation by Application
General Patient Monitoring
Segmentation by End-User
Home Care Settings
Physician Offices & Specialty Clinics
Segmentation by Geography
North America – US, Canada
Europe – Germany, France, UK, Italy, Spain
APAC – China, Japan, India, South Korea, Australia
Latin America – Brazil, Mexico, Argentina
Middle East & Africa – South Africa, Saudi Arabia, Turkey
The global market for electronic skin patches is categorized based on applications, which include diabetes management, general patient monitoring, cardiovascular monitoring, and others. Among these, diabetes management holds the highest share at 43.51% and is projected to reach USD 18.10 billion by 2027.
Diabetes management involves the use of electronic skin patches for continuous glucose monitoring and insulin pumps. General patient monitoring utilizes electronic skin patches to monitor various physiological parameters, primarily focusing on vitals such as temperature, heart rate, pulse rate, and respiratory rate. Cardiovascular monitoring employs electronic skin patches for activities like ECG, EKG, Holter monitoring, mobile cardiac telemetry, and ambulatory cardiac monitoring. The others category encompasses multiple purposes, including cosmetics, sports, fitness and wellness, wound care, electrical stimulation, imaging, fetal monitoring, sleep tracking, stress management, and pharmaceutical applications.
Based on end-users, the global electronic skin patches market includes home care settings, hospitals, physician offices and specialty clinics, and others. Home care settings account for the highest share at 42.80% in 2021. This involves home care providers and individuals using electronic skin patches to monitor and treat various conditions. Hospitals utilize electronic skin patches for monitoring and treatment purposes, while physician offices and specialty clinics, diagnostic centers, sleep labs and clinics, and physiotherapy and rehabilitation centers also rely on these patches. Other users of electronic skin patches include cosmetic clinics, sports and health/wellness centers, pharma and biotech companies, ambulatory surgical centers, and academic and research institutes.
North America holds the largest share at 47.59% in the global electronic skin patches market. This region’s leading position can be attributed to several factors, including the increasing prevalence of cardiac disorders and diabetes, advanced healthcare infrastructure, a rise in wearable devices for healthcare monitoring, the use of IoT-based applications, sensor miniaturization in medical devices, the growing trend of personal health and fitness management, and the demand for skin patches for drug delivery. Within North America, the United States contributes to 94.11% of the market share due to the rising demand for electronic skin patches in managing chronic conditions like cardiovascular diseases and diabetes. Moreover, the high prevalence of various diseases has led to increased adoption of remote monitoring devices.
Europe holds the second-largest revenue share in the global market, primarily driven by its sophisticated healthcare infrastructure and high awareness of the benefits offered by electronic skin patches compared to traditional monitoring options. The Asia-Pacific (APAC) region is expected to emerge as a significant market, with a strong focus on physical health maintenance and continuous monitoring of physiological parameters. Latin America, the Middle East, and Africa have relatively minimal shares in the global electronic skin patches market.
The competitive landscape in the global electronic skin patch market is currently becoming more intense due to the rapidly evolving technological environment in the healthcare industry. Market vendors are employing various strategies to drive growth in the coming years. These strategies include collaboration, partnerships, mergers, acquisitions, and product launches. For example, in February 2021, Philips acquired BioTelemetry, a leading player in the mobile cardiac telemetry market.
Leading medical device companies are opting for an acquisition strategy to invest in or partner with emerging vendors, aiming to diversify their product portfolio and strengthen their presence in the overall market. In April 2020, iRhythm Technologies deployed ZioAT and ZioXT virtual platforms to assist doctors in using telemetry for heart treatment during the COVID-19 pandemic.
The global electronic skin patches market is expected to be highly dynamic, with the participation of major international, regional, and a few local vendors offering electronic skin patches. Abbott, Dexcom, General Electric Company, and Koninklijke Philips are prominent vendors that hold a significant share in the global electronic skin patches market.
Key companies profiled in this report include Abbott, Dexcom, General Electric Company, Koninklijke Philips N.V., Menarini Diagnostics, Bardy Diagnostics, Benware Medical, Bittium, Bloomlife, Blue Spark Technologies, BORSAM Biomedical Instruments, Boston Scientific, Cardiomo, DMS-Service, Epicore Biosystems, FUKUDA DENSHI, Gamastech, Holst Centre, Insulet, iRhythm Technologies, Isansys, LCR Hallcrest, LifeSignals, Liv ApS, Medicomp, Medidata, Medicsensors, Medtrum Technologies, Natures Frequencies, Nemaura Medical, OMRON Healthcare, Onera Technologies B.V., PAINMASTER, QT Medical, Quad Industries, Smith+Nephew, SpotSee, The Surgical Company, Theranica Bio-Electronics, The Scott Fetzer Company, Virility Medical, VitalConnect, VivaLNK, Vivomi, WearOptimo, Xsensio.
Key Questions Answered
What is the projected growth of the global electronic skin patches market?
The global electronic skin patches market is expected to reach USD 28.82 billion by 2027, with a market size valued at USD 9.57 billion in 2021.
What is the compound annual growth rate (CAGR) of the global electronic skin patches market?
The global electronic skin patches market is growing at a CAGR of 20.17% from 2021 to 2027.
What are the latest trends in the global electronic skin patches market?
Some of the latest trends in the global electronic skin patches market include the development of e-skin patches by start-ups and universities, the emergence of innovative electronic skin patch designs, the use of digital tattoos for health monitoring, and the increasing demand for remote patient monitoring.
Who are the key players in the global electronic skin patches market?
The key players in the global electronic skin patches market include Abbott, Dexcom, General Electric Company, and Koninklijke Philips.
Which region dominates the market share of the global electronic skin patches market?
North America dominates the global electronic skin patches market, holding a market share of 47.59%. It is projected to reach a value of USD 16.17 billion by 2027. Significant factors contributing to the region’s market dominance include the high prevalence of cardiac disorders and diabetes, advanced healthcare infrastructure, the adoption of wearable devices for healthcare monitoring, the increasing use of IoT-based applications, and the miniaturization of sensors used in medical devices.